l. A therapeutic preparation in dosage unit form comprising a capsule containing an initial dosage of from 2 to mg. of sympathomimetic selected from the group consisting of a salt of racemic amphetamine, a salt of dextro-amphetamine, a s...
Patented May 22, 1951 ENTEEIC COMPGSITIQN AND METHOD OF MAKING SAME Herman H. Begin, Detroit, and Ernest R. Jones, Grosse Pointe Farms, Mich, assignors to Parke, Davis & Company, Detroit, Mich, a corporation of Michigan No Drawing. Appli...
Patented May 22, 1951 ENTEEIC COMPGSITIQN AND METHOD OF MAKING SAME Herman H. Begin, Detroit, and Ernest R. Jones, Grosse Pointe Farms, Mich, assignors to Parke, Davis & Company, Detroit, Mich, a corporation of Michigan No Drawing. Appli...
A sustained release indomethacin pharmaceutical product is provided that utilizes a pellet formulation encapsulated in a hard gelatin capsule. A portion of the pellets is uncoated for immediate and rapid release of indomethacin for eleva...
In accordance with the present invention, the controlled release formulation contains coated pellets of indomethacin of only one type. The pellet releases indomethacin in both immediate and sustained release form. The immediate release i...
The serum theophylline concentration profiles and clinical efficacy of two sustained-release theophylline tablets (Quibron-T/SR and Theo-Dur) were compared in 13 asthmatic children requiring continuous theophylline therapy. Quibron-T/SR ...
The serum theophylline concentration profiles and clinical efficacy of two sustained-release theophylline tablets (Quibron-T/SR and Theo-Dur) were compared in 13 asthmatic children requiring continuous theophylline therapy. Quibron-T/SR ...
The serum theophylline concentration profiles and clinical efficacy of two sustained-release theophylline tablets (Quibron-T/SR and Theo-Dur) were compared in 13 asthmatic children requiring continuous theophylline therapy. Quibron-T/SR ...
A sustained absorption theophylline-containing pellet for oral administrattion comprises a core of theophylline or a pharmacological equivalent thereof and an organic acid embedded in a polymeric material in a multilayer arrangement and ...
The present invention relates to a new pharmaceutical form for oral use, in the nature of delayed action and controlled absorption medicaments.The form of the present invention comprises an association of miniaturized granules obtained b...
For the treatment of trace element deficiency in animals over a prolonged period of time there is orally administered a tablet containing said trace elemen...
A device for the controlled continuous administration of an active agent to an environment of use is disclosed. The device comprises a body of erodible agent release rate controlling material containing an agent dispersed therethrough; t...
A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slo...
